Why Dr Martens' knock-down share price is too good to resist
Iconic British footwear brand Dr. Martens (DOCS) has been a disappointing investment since coming to the market in early 2021, with the shares losing around 75% of their value after delivering four profit warnings in the past...
14 December 2023